• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在家居护理和门诊护理环境中对心脏病患者进行(N 端前体)B 型利钠肽的即时检测。

Point-of-care testing of (N-terminal pro) B-type natriuretic peptide for heart disease patients in home care and ambulatory care settings.

作者信息

Shimizu Nayuta, Kotani Kazuhiko

机构信息

Division of Community and Family Medicine, Center of Community Medicine, Jichi Medical University, Tochigi, Japan.

出版信息

Pract Lab Med. 2020 Oct 17;22:e00183. doi: 10.1016/j.plabm.2020.e00183. eCollection 2020 Nov.

DOI:10.1016/j.plabm.2020.e00183
PMID:33134469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7585141/
Abstract

OBJECTIVES

The role of point-of-care testing (POCT) out of hospital, especially in home care and ambulatory care settings, is an issue meriting further research. We reviewed studies reporting cardiovascular events as a result of the implementation of B-type natriuretic peptide or N-terminal pro B-type natriuretic peptide POCT (BNP/NT-proBNP POCT) for heart disease patients in the settings.

DESIGN

Articles were searched via a PubMed engine until May 30, 2020.

RESULTS

In total, six studies were selected. Three studies involving ambulatory care used the POCT to refer patients with suspected heart diseases to a specialist. The other three used the tests in home care to monitor patients with heart failure. In ambulatory care, the randomized controlled trials, in which referrals were made to a specialist, showed that the group using POCT had significantly fewer cardiovascular outcomes, such as hospitalizations and deaths, than the non-use group. In home care, adverse outcomes were predicted from changes in BNP levels.

CONCLUSIONS

In most studies, the use of BNP/NT-proBNP POCT in home care and ambulatory care settings demonstrated favorable results regarding the cardiovascular outcomes. The utility of POCT in the settings is suggested, while more investigations are required.

摘要

目的

院外即时检验(POCT)的作用,尤其是在家庭护理和门诊护理环境中的作用,是一个值得进一步研究的问题。我们回顾了有关在这些环境中对心脏病患者实施B型利钠肽或N末端B型利钠肽原即时检验(BNP/NT-proBNP POCT)后报告心血管事件的研究。

设计

通过PubMed引擎检索文章直至2020年5月30日。

结果

总共选择了六项研究。三项涉及门诊护理的研究使用POCT将疑似心脏病患者转诊给专科医生。另外三项在家庭护理中使用这些检测来监测心力衰竭患者。在门诊护理中,将患者转诊给专科医生的随机对照试验表明,使用POCT的组与未使用组相比,心血管结局(如住院和死亡)明显更少。在家庭护理中,根据BNP水平的变化预测不良结局。

结论

在大多数研究中,在家庭护理和门诊护理环境中使用BNP/NT-proBNP POCT在心血管结局方面显示出良好的结果。建议在这些环境中使用POCT,同时还需要更多的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e65f/7585141/d7845b1ff3f1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e65f/7585141/d7845b1ff3f1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e65f/7585141/d7845b1ff3f1/gr1.jpg

相似文献

1
Point-of-care testing of (N-terminal pro) B-type natriuretic peptide for heart disease patients in home care and ambulatory care settings.在家居护理和门诊护理环境中对心脏病患者进行(N 端前体)B 型利钠肽的即时检测。
Pract Lab Med. 2020 Oct 17;22:e00183. doi: 10.1016/j.plabm.2020.e00183. eCollection 2020 Nov.
2
The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.心血管危险因素稳定门诊患者中N末端B型利钠肽原/ B型利钠肽的摩尔比与心力衰竭相关事件的关系
Intern Med. 2018 Sep 15;57(18):2621-2630. doi: 10.2169/internalmedicine.0471-17. Epub 2018 Apr 27.
3
How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.B 型利钠肽(BNP)和体重变化在射血分数保留型心力衰竭与射血分数降低型心力衰竭中的差异:HABIT(家庭中 BNP 用于心力衰竭评估)试验的次要结果。
J Card Fail. 2016 Apr;22(4):283-93. doi: 10.1016/j.cardfail.2015.09.014. Epub 2015 Oct 31.
4
Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.哪些心力衰竭患者从利钠肽指导的治疗中获益?来自随机试验个体患者数据的荟萃分析。
Eur J Heart Fail. 2015 Dec;17(12):1252-61. doi: 10.1002/ejhf.401. Epub 2015 Sep 30.
5
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭和射血分数降低患者中 BNP 和 NT-proBNP 的比较。
Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17.
6
Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.利钠肽变化预测慢性心力衰竭患者的住院:一项荟萃分析。
JACC Heart Fail. 2014 Apr;2(2):148-58. doi: 10.1016/j.jchf.2013.11.007.
7
Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.联合应用氨基末端 pro-B 型利钠肽原和 B 型利钠肽对心力衰竭住院患者预后的评估。
Clin Chim Acta. 2019 Apr;491:8-14. doi: 10.1016/j.cca.2018.12.025. Epub 2018 Dec 28.
8
Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.在初级和二级保健中,心力衰竭患者的血清 B 型利钠肽检测和监测的有效性和成本效益:证据综合、队列研究和成本效益模型。
Health Technol Assess. 2017 Aug;21(40):1-150. doi: 10.3310/hta21400.
9
N-Terminal-pro-Brain natriuretic peptide dynamics during effort phenotypes ischemic heart failure and determines prognosis regardless of ejection fraction.在努力表型缺血性心力衰竭期间,N 端前脑利钠肽动力学变化并确定预后,而不取决于射血分数。
Peptides. 2020 Jul;129:170315. doi: 10.1016/j.peptides.2020.170315. Epub 2020 Apr 22.
10
Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.N 端脑利钠肽前体在射血分数保留型、中间范围型和降低型心力衰竭中的相关性及其预后和鉴别诊断作用。
J Card Fail. 2018 Jun;24(6):365-374. doi: 10.1016/j.cardfail.2018.03.010. Epub 2018 Mar 27.

引用本文的文献

1
Smartphone-based rapid quantitative detection of serum creatinine: Performance validation and exploration of potential application in chronic kidney disease monitoring.基于智能手机的血清肌酐快速定量检测:性能验证及在慢性肾脏病监测中的潜在应用探索
Medicine (Baltimore). 2025 May 16;104(20):e42508. doi: 10.1097/MD.0000000000042508.
2
Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers.炎症与心血管系统:聚焦细胞因子和心脏特异性生物标志物。
Int J Mol Sci. 2023 Jan 3;24(1):844. doi: 10.3390/ijms24010844.
3
Mixed-methods evaluation of a multifaceted heart failure intervention in general practice: the OSCAR-HF pilot study.

本文引用的文献

1
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure - Digest Version.《日本循环学会2017年/日本心力衰竭学会2017年急性和慢性心力衰竭诊断与治疗指南 - 摘要版》
Circ J. 2019 Sep 25;83(10):2084-2184. doi: 10.1253/circj.CJ-19-0342. Epub 2019 Sep 10.
2
Natriuretic Peptides in Chronic Heart Failure.慢性心力衰竭中的利钠肽
Card Fail Rev. 2019 Feb;5(1):44-49. doi: 10.15420/cfr.2018.26.1.
3
B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.
综合实践中多方面心力衰竭干预措施的混合方法评价:OSCAR-HF 试点研究。
ESC Heart Fail. 2023 Apr;10(2):907-916. doi: 10.1002/ehf2.14251. Epub 2022 Dec 3.
4
Utilization of point-of-care tests among general practitioners, a cross-sectional study.基层医生对即时检测的利用:一项横断面研究。
BMC Prim Care. 2022 Mar 9;23(1):41. doi: 10.1186/s12875-022-01643-9.
5
Combination of Prehospital NT-proBNP with qSOFA and NEWS to Predict Sepsis and Sepsis-Related Mortality.联合院前 NT-proBNP 与 qSOFA 和 NEWS 预测脓毒症和脓毒症相关死亡率。
Dis Markers. 2022 Feb 23;2022:5351137. doi: 10.1155/2022/5351137. eCollection 2022.
B 型利钠肽指导心力衰竭(HF)治疗:个体参与者数据(IPD)和汇总数据的系统评价和荟萃分析。
Syst Rev. 2018 Jul 31;7(1):112. doi: 10.1186/s13643-018-0776-8.
4
Diagnostic accuracy of point-of-care natriuretic peptide testing for chronic heart failure in ambulatory care: systematic review and meta-analysis.在门诊护理中使用床边利钠肽检测诊断慢性心力衰竭的准确性:系统评价和荟萃分析。
BMJ. 2018 May 21;361:k1450. doi: 10.1136/bmj.k1450.
5
Does natriuretic peptide monitoring improve outcomes in heart failure patients? A systematic review and meta-analysis.利钠肽监测能否改善心力衰竭患者的预后?系统评价和荟萃分析。
Int J Cardiol. 2018 Jul 15;263:80-87. doi: 10.1016/j.ijcard.2018.04.049. Epub 2018 Apr 12.
6
Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study.心力衰竭患者在家中每日监测 BNP 以预测临床恶化:来自 HOME HF 研究的结果。
Eur J Heart Fail. 2018 Mar;20(3):474-480. doi: 10.1002/ejhf.1053. Epub 2018 Jan 4.
7
Heart failure: preventing disease and death worldwide.心力衰竭:全球范围内预防疾病与死亡
ESC Heart Fail. 2014 Sep;1(1):4-25. doi: 10.1002/ehf2.12005.
8
Effectiveness of natriuretic peptide-guided treatment of chronic heart failure. A meta-analysis.利钠肽指导治疗慢性心力衰竭的有效性:一项荟萃分析。
Arch Cardiol Mex. 2018 Jul-Sep;88(3):171-177. doi: 10.1016/j.acmx.2017.02.008. Epub 2017 Apr 11.
9
B-type natriuretic peptide-guided treatment for heart failure.B型利钠肽指导下的心力衰竭治疗
Cochrane Database Syst Rev. 2016 Dec;12(12):CD008966. doi: 10.1002/14651858.CD008966.pub2. Epub 2016 Dec 22.
10
Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.心力衰竭患者初级保健机构转诊进行超声心动图检查(REFER):一项诊断准确性研究。
Br J Gen Pract. 2017 Feb;67(655):e94-e102. doi: 10.3399/bjgp16X688393. Epub 2016 Dec 5.